MRI contrast media: what clinicians need to know

Area of Science:

• Medical Imaging
• Radiology
• Biophysics

Background:

• Magnetic resonance imaging (MRI) utilizes proton spinning in a magnetic field for cross-sectional body imaging.
• MRI is advantageous due to its lack of ionizing radiation and superior soft tissue contrast.
• Contrast media, like gadolinium chelates, were developed after MRI's initial use to further enhance imaging.

Purpose of the Study:

• To review the development and application of MRI contrast agents.
• To discuss the safety and adverse effects associated with MRI contrast agents.
• To highlight the impact of nephrogenic systemic fibrosis on the usage of these agents.

Main Methods:

• Review of literature on MRI technology and contrast agents.
• Analysis of the types and applications of extracellular and tissue-specific contrast agents.
• Examination of safety profiles and known adverse effects, including nephrogenic systemic fibrosis.

Main Results:

• Gadolinium-based contrast agents are generally well-tolerated.
• Tissue-specific agents offer specialized diagnostic capabilities but carry some adverse effects.
• The identification of nephrogenic systemic fibrosis has led to revised guidelines for contrast agent use.

Conclusions:

• MRI is a valuable, non-ionizing imaging technique with excellent soft tissue contrast.
• While MRI contrast agents improve diagnostic accuracy, their use necessitates careful consideration of risks, particularly nephrogenic systemic fibrosis.
• Ongoing research aims to balance the benefits of contrast enhancement with patient safety.